These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 17303282)

  • 81. Insulin-induced lipohypertrophy: report of a case with histopathology.
    Fujikura J; Fujimoto M; Yasue S; Noguchi M; Masuzaki H; Hosoda K; Tachibana T; Sugihara H; Nakao K
    Endocr J; 2005 Oct; 52(5):623-8. PubMed ID: 16284443
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Pictures in medicine 12. Insulin-induced lipohypertrophy.
    Iqbal P
    Br J Hosp Med; 1996 Feb 7-20; 55(3):138. PubMed ID: 8907880
    [No Abstract]   [Full Text] [Related]  

  • 83. Insulin-injection-site reactions associated with type I latex allergy.
    Roest MA; Shaw S; Orton DI
    N Engl J Med; 2003 Jan; 348(3):265-6. PubMed ID: 12529475
    [No Abstract]   [Full Text] [Related]  

  • 84. A case of Mycobacterium abscessus infection presenting as a cystic lesion in an insulin injection site in a diabetic patient.
    Shibayama Y; Imafuku S; Koga K; Tatsukawa R; Nakayama J
    J Dermatol; 2014 May; 41(5):469-70. PubMed ID: 24628302
    [No Abstract]   [Full Text] [Related]  

  • 85. Lipohypertrophy in Individuals with Type 2 Diabetes: Prevalence and Risk Factors.
    Sürücü HA; OKur Arslan H
    J Caring Sci; 2018 Jun; 7(2):67-74. PubMed ID: 29977876
    [No Abstract]   [Full Text] [Related]  

  • 86. The incidence of lipodystrophy in juvenile diabetics.
    Traisman HS; McLain LG
    IMJ Ill Med J; 1968 Jun; 133(6):732-4 passim. PubMed ID: 4385275
    [No Abstract]   [Full Text] [Related]  

  • 87. Insulin-related lipohypertrophy: ultrasound characteristics, risk factors, and impact of glucose fluctuations.
    Lin Y; Lin L; Wang W; Hong J; Zeng H
    Endocrine; 2022 Mar; 75(3):768-775. PubMed ID: 34648113
    [TBL] [Abstract][Full Text] [Related]  

  • 88. A meta-analysis and meta-regression on the prevalence of lipohypertrophy in diabetic patients on insulin therapy.
    Wang K; Zhang S; Liu C; Chen Y
    Therapie; 2021; 76(6):617-628. PubMed ID: 33958198
    [TBL] [Abstract][Full Text] [Related]  

  • 89. [Biosynthetic insulin. A treatment method in diabetic lipoatrophy].
    Hansen LB; Permin H; Asfeldt V
    Ugeskr Laeger; 1988 May; 150(21):1292-4. PubMed ID: 3289218
    [No Abstract]   [Full Text] [Related]  

  • 90. Severe insulin-induced lipohypertrophy successfully treated by liposuction.
    Hardy KJ; Gill GV; Bryson JR
    Diabetes Care; 1993 Jun; 16(6):929-30. PubMed ID: 8325209
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Early rapid onset lipohypertrophy in a patient with type 1 diabetes mellitus.
    Bird P; Fowler I; Boyle MJ
    Aust N Z J Med; 1998 Aug; 28(4):467-8. PubMed ID: 9777118
    [No Abstract]   [Full Text] [Related]  

  • 92. Is the reuse of needles for insulin injection systems associated with a higher risk of cutaneous complications?
    Schuler G; Pelz K; Kerp L
    Diabetes Res Clin Pract; 1992 Jun; 16(3):209-12. PubMed ID: 1425141
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Frequency of lipodystrophy induced by recombinant human insulin.
    Hajheydari Z; Kashi Z; Akha O; Akbarzadeh S
    Eur Rev Med Pharmacol Sci; 2011 Oct; 15(10):1196-201. PubMed ID: 22165682
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Lipohypertrophy and glomerulonephritis after the use of aprotinin in an insulin-dependent diabetic.
    Boag F; Chappell M; Beckett AG; Dandona P
    N Engl J Med; 1985 Jan; 312(4):245-6. PubMed ID: 2578215
    [No Abstract]   [Full Text] [Related]  

  • 95. Accuracy of injection site identification among children with insulin dependent diabetes mellitus: a comparison of traditional and new visual aids.
    Monaco L; Geffken G; Silverstein JH
    Clin Pediatr (Phila); 1996 Apr; 35(4):191-7. PubMed ID: 8665752
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Hundred-year experience with insulin and lipohypertrophy: An unresolved issue.
    Di Bartolo P; Eckel RH; Strollo F; Gentile S
    Diabetes Res Clin Pract; 2021 Aug; 178():108924. PubMed ID: 34153354
    [TBL] [Abstract][Full Text] [Related]  

  • 97. LIPODYSTROPHY FREQUENCY ACCORDING TO INSULIN TREATMENT REGIMEN IN TYPE 2 DIABETIC PATIENTS: IS INSULIN INJECTION FREQUENCY MATTERS IN ANALOG INSULIN ERA?
    Gunhan HG; Elbasan O; Imre E; Yavuz DG
    Acta Endocrinol (Buchar); 2022; 18(2):202-208. PubMed ID: 36212263
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Non-glycemic Adverse Effects of Insulin.
    Guarneri AM; Hoffman RP
    Curr Diabetes Rev; 2022; 18(2):e012821190877. PubMed ID: 33511950
    [TBL] [Abstract][Full Text] [Related]  

  • 99. [Painless and tissue sparing. Insulin injection without needle].
    MMW Fortschr Med; 2002 Jul; 144(29-30):55. PubMed ID: 12219617
    [No Abstract]   [Full Text] [Related]  

  • 100. Insulin amyloid at injection sites of patients with diabetes.
    Nilsson MR
    Amyloid; 2016 Sep; 23(3):139-147. PubMed ID: 27159045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.